Vancomycin pharmacokinetic parameters in patients undergoing hematopoietic stem cell transplantation
- 11 January 2021
- journal article
- research article
- Published by SAGE Publications in Journal of Oncology Pharmacy Practice
- Vol. 28 (1) , 101-108
Abstract
Introduction: Current guidelines on vancomycin dosing lack specific recommendations about its dosing in hematopoietic stem cell transplant (HSCT) patients, the objective of the current study was to compare vancomycin pharmacokinetic variables in this population with those of general population. Methods: A prospective study was designed and the calculated parameters of vancomycin pharmacokinetic were compared with individualized parameters. Two trough levels before 4th and 5th doses and a peak level after the 4th dose, were taken. All patients received a dose of 15 mg/kg of vancomycin two or three times a day. Pharmacokinetic parameters were calculated using a one compartmental model. The association between different variables and of acute kidney injury (AKI) development and achievement of target levels were also evaluated. Results: A significant difference was observed between population Volume of distribution (Vd) and individualized Vd (mean 57.33 L vs 162.86 L, p value 0.019) and trough and peak levels (p values 0.0001 and 0.001; for mean trough and peak levels respectively). The achievement of the recommended trough levels and area under the concentration time curve per minimum inhibitory concentration (AUC24/MIC) was very low (5/71 and 24/71 patients respectively). No significant differences were observed between population and individualized clearance and rate of elimination of vancomycin (p values of 0.092 and 0.55 respectively). Concomitant receipt of cyclosporine was significantly related with development of AKI (p value 0.046). Conclusion: The dosing methods which use population-based pharmacokinetic variables does not result in desired therapeutic levels in HSCT patients, mainly because of larger vancomycin volume of distribution.Keywords
This publication has 22 references indexed in Scilit:
- BACTERIAL INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTSMediterranean Journal of Hematology and Infectious Diseases, 2015
- Augmented Renal Vancomycin Clearance in Cancer Patients: A Case Report and Review of the LiteratureOncology Research and Treatment, 2015
- Utility of surveillance blood cultures in patients undergoing hematopoietic stem cell transplantationAntimicrobial Resistance & Infection Control, 2014
- NoticeKidney International Supplements, 2012
- Mortality after bloodstream infections in allogeneic haematopoietic stem cell transplant (HSCT) recipientsInfection, 2011
- Characterization of vancomycin pharmacokinetics in the adult acute myeloid leukemia populationJournal of Oncology Pharmacy Practice, 2011
- Predictors and outcome of acute kidney injury in patients with acute myelogenous leukemia or high‐risk myelodysplastic syndromeCancer, 2010
- Pharmacokinetics of vancomycin in adult cancer patientsJournal of Oncology Pharmacy Practice, 2009
- Blood Stream Infections in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Reemergence of Gram-Negative Rods and Increasing Antibiotic ResistanceTransplantation and Cellular Therapy, 2009
- Vancomycin Pharmacokinetics in a Patient PopulationTherapeutic Drug Monitoring, 1994